Literature DB >> 11879992

Efficiency and safety of chemotherapy plans for children: CATIPO--a nationwide approach.

Petra Knaup1, Timm Wiedemann, Andreas Bachert, Ursula Creutzig, Reinhold Haux, Freimut Schilling.   

Abstract

Chemotherapy is an important component of childhood cancer treatment. Due to the intensity of this therapy, an error in calculating the dosage of the cytostatic drugs would have severe consequences. Therefore, a computer-aided therapy planning system in pediatric oncology (CATIPO) was introduced into routine use in approximately 20 clinics across Germany. The system consists of a knowledge acquisition module for acquiring knowledge about chemotherapy protocols and a decision support module for producing a patient-specific therapy plan. The main benefits of the system are the reduction of errors and saving time during the development of a particular therapy plan. CATIPO's success is based on the enormous demand for this kind of decision support and its development in tight cooperation with future users.

Entities:  

Mesh:

Year:  2002        PMID: 11879992     DOI: 10.1016/s0933-3657(01)00106-3

Source DB:  PubMed          Journal:  Artif Intell Med        ISSN: 0933-3657            Impact factor:   5.326


  3 in total

1.  Computer calculated dose in paediatric prescribing.

Authors:  Richard C Kirk; Denise Li-Meng Goh; Jeya Packia; Huey Min Kam; Benjamin K C Ong
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  Computerized clinical decision support for prescribing: provision does not guarantee uptake.

Authors:  Annette Moxey; Jane Robertson; David Newby; Isla Hains; Margaret Williamson; Sallie-Anne Pearson
Journal:  J Am Med Inform Assoc       Date:  2010 Jan-Feb       Impact factor: 4.497

3.  A Clinical Decision Support System for Increasing Compliance with Protocols in Chemotherapy of Children with Acute Lymphoblastic Leukemia.

Authors:  Hamid Moghaddasi; Rezvan Rahimi; Alireza Kazemi; Khadijeh Arjmandi Rafsanjani; Gholamreza Bahoush; Forough Rahimi
Journal:  Cancer Inform       Date:  2022-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.